Browse studies
Find your next paid study
15 recruiting studies matching your filters
Observational
my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
This study aims to design and test a novel, personalized digital intervention-my.naviGATE-for adolescent and young adults (AYA) with cancer. my.naviGATE is a m…
SarcomaOsteosarcomaEwing Sarcoma+6 more
Estimated
~$10 – $7,500
Dana-Farber Cancer InstituteNCT07516353
Phase 1
A Phase 1 / 2, Open-Label Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
This is a multi-center, open-label study to investigate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary activity of REC…
UnresectableLocally AdvancedMetastatic Cancers+1 more
Estimated
~$10 – $8,750
Recursion Pharmaceuticals Inc.NCT06678659
Phase 2
A Phase II Trial of JAK Inhibitor Added to Immunotherapy for Treatment of Relapsed/Refractory T-cell Lymphoma and 9p Amplified Lymphomas
The purpose of this study is to understand and determine if ruxolitinib added to pembrolizumab is safe and effective for the treatment of relapsed or refractor…
Non-Hodgkin LymphomaHodgkin Disease LymphomaNon-Hodgkin Lymphoma Refractory/ Relapsed+5 more
Estimated
~$10 – $7,500
Seda S. ToluNCT07283822